|
|
Previous Article | Table of Contents | Next Article 
Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia
gene FAC in the Ashkenazi Jewish population
PC Verlander, A Kaporis, Q Liu, Q Zhang, U Seligsohn and AD Auerbach
Laboratory of Human Genetics and Hematology, Rockefeller University, New
York, NY 10021-6399, USA.
Fanconi anemia (FA) is a genetically and phenotypically heterogeneous
autosomal recessive disorder defined by a cellular hypersensitivity to DNA
cross-linking agents. One of the FA genes, FAC, has been cloned and the
genomic structure of the coding region has been characterized. We have
developed amplification refractory mutation system (ARMS) assays for five
known mutations in FAC, and have applied these assays to determine the
carrier frequency of the IVS4 + 4 A-->T (IVS4) mutation in an Ashkenazi
Jewish population. We tested 3,104 Jewish individuals, primarily of
Ashkenazi descent, for the two most common FAC mutations, IVS4 and 322delG.
Thirty-five IVS4 carriers were identified, for a carrier frequency of 1 in
89 (1.1%; 95% confidence interval 0.79% to 1.56%); no 322delG carriers were
found. To determine if the IVS4 mutation was confined to the Ashkenazi
Jewish population, we tested 563 Iraqi Jews for IVS4, and no carriers were
found. Because the IVS4 mutation has only been found on chromosomes of
Ashkenazi Jewish origin and is the only FAC mutation found on these
chromosomes, we suggest that a founder effect is responsible for the high
frequency of this mutation. With a carrier frequency greater than 1% and
simple testing available, the IVS4 mutation merits inclusion in the battery
of tests routinely provided to the Jewish population.
Volume 86,
Issue 11,
pp. 4034-4038,
12/01/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Kalman, J. A. Wilson, A. Buller, J. Dixon, L. Edelmann, L. Geller, W. E. Highsmith, L. Holtegaard, R. Kornreich, E. M. Rohlfs, et al.
Development of Genomic DNA Reference Materials for Genetic Testing of Disorders Common in People of Ashkenazi Jewish Descent
J. Mol. Diagn.,
November 1, 2009;
11(6):
530 - 536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Berwick, J. M. Satagopan, L. Ben-Porat, A. Carlson, K. Mah, R. Henry, R. Diotti, K. Milton, K. Pujara, T. Landers, et al.
Genetic Heterogeneity among Fanconi Anemia Heterozygotes and Risk of Cancer
Cancer Res.,
October 1, 2007;
67(19):
9591 - 9596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Rosenberg, Y. Huang, and B. P. Alter
Individualized risks of first adverse events in patients with Fanconi anemia
Blood,
July 15, 2004;
104(2):
350 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Wagner, J. Tolar, O. Levran, T. Scholl, A. Deffenbaugh, J. Satagopan, L. Ben-Porat, K. Mah, S. D. Batish, D. I. Kutler, et al.
Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia
Blood,
April 15, 2004;
103(8):
3226 - 3229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Offit, O. Levran, B. Mullaney, K. Mah, K. Nafa, S. D. Batish, R. Diotti, H. Schneider, A. Deffenbaugh, T. Scholl, et al.
Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia
J Natl Cancer Inst,
October 15, 2003;
95(20):
1548 - 1551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. I. Kutler, B. Singh, J. Satagopan, S. D. Batish, M. Berwick, P. F. Giampietro, H. Hanenberg, and A. D. Auerbach
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Blood,
February 15, 2003;
101(4):
1249 - 1256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M D Tischkowitz and S V Hodgson
Fanconi anaemia
J. Med. Genet.,
January 1, 2003;
40(1):
1 - 10.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. D. D'Andrea, N. Dahl, E. C. Guinan, and A. Shimamura
Marrow Failure
Hematology,
January 1, 2002;
2002(1):
58 - 72.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Grompe and A. D'Andrea
Fanconi anemia and DNA repair
Hum. Mol. Genet.,
October 1, 2001;
10(20):
2253 - 2259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Tipping, T. Pearson, N. V. Morgan, R. A. Gibson, L. P. Kuyt, C. Havenga, E. Gluckman, H. Joenje, T. de Ravel, S. Jansen, et al.
Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa
PNAS,
May 8, 2001;
98(10):
5734 - 5739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Wajnrajch, J. M. Gertner, Z. Huma, J. Popovic, K. Lin, P. C. Verlander, S. D. Batish, P. F. Giampietro, J. G. Davis, M. I. New, et al.
Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry
Pediatrics,
April 1, 2001;
107(4):
744 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Futaki, T. Yamashita, H. Yagasaki, T. Toda, M. Yabe, S. Kato, S. Asano, and T. Nakahata
The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients
Blood,
February 15, 2000;
95(4):
1493 - 1498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Ph. Guardiola, R. Pasquini, I. Dokal, J. J. Ortega, M. van Weel-Sipman, J. C. W. Marsh, S. E. Ball, F. Locatelli, C. Vermylen, R. Skinner, et al.
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation
Blood,
January 15, 2000;
95(2):
422 - 429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Oddoux
Mendelian Diseases among Roman Jews: Implications for the Origins of Disease Alleles
J. Clin. Endocrinol. Metab.,
December 1, 1999;
84(12):
4405 - 4409.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Yamashita, G. M. Kupfer, D. Naf, A. Suliman, H. Joenje, S. Asano, and A. D. D'Andrea
The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation
PNAS,
October 27, 1998;
95(22):
13085 - 13090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kronn, V. Jansen, and H. Ostrer
Carrier Screening for Cystic Fibrosis, Gaucher Disease, and Tay-Sachs Disease in the Ashkenazi Jewish Population: The First 1000 Cases at New York University Medical Center, New York, NY
Arch Intern Med,
April 13, 1998;
158(7):
777 - 781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Gillio, P. C. Verlander, S.D. Batish, P.F. Giampietro, and A. D. Auerbach
Phenotypic Consequences of Mutations in the Fanconi Anemia FAC Gene: An International Fanconi Anemia Registry Study
Blood,
July 1, 1997;
90(1):
105 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|